• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients.候选基因分析在血液透析患者动静脉瘘失败中的应用。
Clin J Am Soc Nephrol. 2013 Aug;8(8):1358-66. doi: 10.2215/CJN.11091012. Epub 2013 Apr 4.
2
Calcification in arteriovenous fistula blood vessels may predict arteriovenous fistula failure: a 5-year follow-up study.动静脉内瘘血管钙化可能预示动静脉内瘘失败:一项5年随访研究
Int Urol Nephrol. 2017 May;49(5):881-887. doi: 10.1007/s11255-017-1515-0. Epub 2017 Jan 25.
3
Thrombophilia and arteriovenous fistula survival in ESRD.血栓形成倾向与终末期肾病患者动静脉瘘的生存
Clin J Am Soc Nephrol. 2013 Jun;8(6):962-8. doi: 10.2215/CJN.03860412. Epub 2013 Feb 14.
4
Catheter Dependence After Arteriovenous Fistula or Graft Placement Among Elderly Patients on Hemodialysis.老年血液透析患者动静脉瘘或移植物置管后的导管依赖。
Am J Kidney Dis. 2021 Sep;78(3):399-408.e1. doi: 10.1053/j.ajkd.2020.12.019. Epub 2021 Feb 12.
5
Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.2012-2014 年有医疗保险的新进入血液透析患者动静脉通路的临床结局。
Am J Nephrol. 2019;49(2):156-164. doi: 10.1159/000495355. Epub 2019 Jan 24.
6
Arteriovenous fistula use and heart disease in long-term elderly hemodialysis patients: analysis of United States Renal Data System Dialysis Morbidity and Mortality Wave II.长期老年血液透析患者动静脉内瘘的使用与心脏病:美国肾脏数据系统透析发病率和死亡率研究第二波分析
J Nephrol. 2003 Nov-Dec;16(6):822-30.
7
Incidence and risk factors of sepsis in hemodialysis patients in the United States.美国血液透析患者中脓毒症的发生率及危险因素。
J Vasc Surg. 2021 Mar;73(3):1016-1021.e3. doi: 10.1016/j.jvs.2020.06.126. Epub 2020 Jul 21.
8
Trends in incident hemodialysis access and mortality.血液透析通路事件发生率和死亡率的变化趋势。
JAMA Surg. 2015 May;150(5):441-8. doi: 10.1001/jamasurg.2014.3484.
9
Assessment of Use of Arteriovenous Graft vs Arteriovenous Fistula for First-time Permanent Hemodialysis Access.评估动静脉移植物与动静脉瘘在首次永久性血液透析通路中的应用。
JAMA Surg. 2019 Sep 1;154(9):844-851. doi: 10.1001/jamasurg.2019.1736.
10
Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns study.在透析结果和实践模式研究中,持续使用阿司匹林与初发血液透析患者动静脉内瘘存活率提高相关。
Clin J Am Soc Nephrol. 2008 Sep;3(5):1373-8. doi: 10.2215/CJN.00130108. Epub 2008 Jul 2.

引用本文的文献

1
Future research directions to improve fistula maturation and reduce access failure.改善内瘘成熟度并减少通路失败的未来研究方向。
Semin Vasc Surg. 2016 Dec;29(4):153-171. doi: 10.1053/j.semvascsurg.2016.08.005. Epub 2016 Aug 26.
2
The molecular mechanisms of hemodialysis vascular access failure.血液透析血管通路失败的分子机制
Kidney Int. 2016 Feb;89(2):303-316. doi: 10.1016/j.kint.2015.12.019.
3
Candidate Gene Analysis of Mortality in Dialysis Patients.透析患者死亡率的候选基因分析
PLoS One. 2015 Nov 20;10(11):e0143079. doi: 10.1371/journal.pone.0143079. eCollection 2015.
4
A Patient with Recurrent Arteriovenous Graft Thrombosis.一名患有复发性动静脉移植物血栓形成的患者。
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2255-62. doi: 10.2215/CJN.00190115. Epub 2015 Apr 16.
5
Role of pharmacogenomics in dialysis and transplantation.药物基因组学在透析和移植中的作用。
Curr Opin Nephrol Hypertens. 2014 Nov;23(6):570-7. doi: 10.1097/MNH.0000000000000065.
6
Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?新型血液透析血管通路模式:下游血管生物学——是否存在共同的最终途径?
Clin J Am Soc Nephrol. 2013 Dec;8(12):2194-201. doi: 10.2215/CJN.03490413. Epub 2013 Aug 29.

本文引用的文献

1
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients.透析患者中肺栓塞、心肌梗死和中风导致的死亡率。
J Thromb Haemost. 2012 Dec;10(12):2484-93. doi: 10.1111/j.1538-7836.2012.04921.x.
2
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.鉴定和测试肠易激综合征(IBS)的候选遗传多态性:与 TNFSF15 和 TNFα 的关联。
Gut. 2013 Jul;62(7):985-94. doi: 10.1136/gutjnl-2011-301213. Epub 2012 Jun 8.
3
Preexisting venous calcification prior to dialysis vascular access surgery.透析血管通路手术前已存在的静脉钙化。
Semin Dial. 2012 Sep-Oct;25(5):592-5. doi: 10.1111/j.1525-139X.2012.01063.x. Epub 2012 Mar 27.
4
Association of factor V gene polymorphism with arteriovenous graft failure.因子 V 基因多态性与动静脉移植物失败的关系。
Am J Kidney Dis. 2012 May;59(5):682-8. doi: 10.1053/j.ajkd.2011.11.036. Epub 2012 Jan 24.
5
Factors affecting the patency of arteriovenous fistulas for dialysis access.影响透析通路动静脉瘘通畅的因素。
J Vasc Surg. 2012 Mar;55(3):849-55. doi: 10.1016/j.jvs.2011.07.095. Epub 2011 Nov 8.
6
Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1.腹主动脉瘤与载脂蛋白 E 基因多态性相关。
Am J Hum Genet. 2011 Nov 11;89(5):619-27. doi: 10.1016/j.ajhg.2011.10.002. Epub 2011 Nov 4.
7
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
8
A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.一项全基因组关联研究鉴定出 12 号染色体上的一个区域可能是经皮冠状动脉介入治疗后再狭窄的易感性位点。
Hum Mol Genet. 2011 Dec 1;20(23):4748-57. doi: 10.1093/hmg/ddr389. Epub 2011 Aug 30.
9
Age- and gender-specific epistasis between ADA and TNF-α influences human life-expectancy.年龄和性别特异性的 ADA 和 TNF-α 之间的上位性影响人类预期寿命。
Cytokine. 2011 Nov;56(2):481-8. doi: 10.1016/j.cyto.2011.07.023. Epub 2011 Aug 23.
10
Outcomes of arteriovenous fistula creation after the Fistula First Initiative.瘘管优先倡议后的动静脉瘘管创建的结果。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1996-2002. doi: 10.2215/CJN.11251210. Epub 2011 Jul 7.

候选基因分析在血液透析患者动静脉瘘失败中的应用。

Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients.

机构信息

Departments of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Clin J Am Soc Nephrol. 2013 Aug;8(8):1358-66. doi: 10.2215/CJN.11091012. Epub 2013 Apr 4.

DOI:10.2215/CJN.11091012
PMID:23559680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3731912/
Abstract

BACKGROUND AND OBJECTIVES

Arteriovenous fistula (AVF) failure remains an important cause of morbidity in hemodialysis patients. The exact underlying mechanisms responsible for AVF failure are unknown but processes like proliferation, inflammation, vascular remodeling, and thrombosis are thought to be involved. The current objective was to investigate the association between AVF failure and single nucleotide polymorphisms (SNPs) in genes related to these pathophysiologic processes in a large population of incident hemodialysis patients.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 479 incident hemodialysis patients were included between January 1997 and April 2004. Follow-up lasted 2 years or until AVF failure, defined as surgery, percutaneous endovascular intervention, or abandonment of the vascular access. Forty-three SNPs in 26 genes, related to proliferation, inflammation, endothelial function, vascular remodeling, coagulation, and calcium/phosphate metabolism, were genotyped. Relations were analyzed using Cox regression analysis.

RESULTS

In total, 207 (43.2%) patients developed AVF failure. After adjustment, two SNPs were significantly associated with an increased risk of AVF failure. The hazard ratio (95% confidence interval) of LRP1 rs1466535 was 1.75 (1.15 to 2.66) and patients with factor V Leiden had a hazard ratio of 2.54 (1.41 to 4.56) to develop AVF failure. The other SNPs were not associated with AVF failure.

CONCLUSIONS

In this large cohort of hemodialysis patients, only 2 of the 43 candidate SNPs were associated with an increased risk of AVF failure. Whether other factors, like local hemodynamic circumstances, are more important or other SNPs play a role in AVF failure remains to be elucidated.

摘要

背景与目的

动静脉瘘(AVF)失功仍然是血液透析患者发病率的一个重要原因。导致 AVF 失功的确切潜在机制尚不清楚,但增殖、炎症、血管重塑和血栓形成等过程被认为与之相关。本研究的目的是在一个大型的血液透析患者队列中,研究与这些病理生理过程相关的基因中的单核苷酸多态性(SNP)与 AVF 失功之间的相关性。

设计、地点、参与者和测量方法:总共纳入了 1997 年 1 月至 2004 年 4 月期间的 479 名新发病的血液透析患者。随访时间为 2 年或直至 AVF 失功,AVF 失功的定义为手术、经皮腔内血管介入治疗或废弃血管通路。对与增殖、炎症、内皮功能、血管重塑、凝血和钙/磷代谢相关的 26 个基因中的 43 个 SNP 进行了基因分型。使用 Cox 回归分析来分析相关性。

结果

总共 207 名(43.2%)患者发生了 AVF 失功。经调整后,有两个 SNP 与 AVF 失功风险增加显著相关。LRP1 rs1466535 的危险比(95%置信区间)为 1.75(1.15 至 2.66),因子 V Leiden 患者发生 AVF 失功的危险比为 2.54(1.41 至 4.56)。其他 SNP 与 AVF 失功无关。

结论

在本大型血液透析患者队列中,只有 43 个候选 SNP 中的 2 个与 AVF 失功风险增加相关。局部血液动力学情况等其他因素是否更重要或其他 SNP 是否在 AVF 失功中起作用,仍有待阐明。